Kanako Otani
Overview
Explore the profile of Kanako Otani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Otani K, Kimura R, Nagasawa N, Hayashi Y, Ohmiya S, Watanabe O, et al.
Microorganisms
. 2025 Feb;
13(2).
PMID: 40005750
To better understand the phylogenomics of the hemagglutinin-neuraminidase () gene and HN protein in human parainfluenza virus type 4 (HPIV4), we performed phylogenomic analyses using various bioinformatics methods. The main...
2.
Mitsushima S, Yahata Y, Tsuchihashi Y, Ikenoue C, Fukusumi M, Otake S, et al.
Emerg Infect Dis
. 2024 Jul;
30(8):1589-1598.
PMID: 39043405
To determine the characteristics of pediatric patients 0-19 years of age who died after onset of SARS-CoV-2 infection in Japan during January 1-September 30, 2022, we reviewed multiple sources. We...
3.
Arima Y, Tsuchihashi Y, Takahara O, Shimbashi R, Arashiro T, Kasamatsu A, et al.
Western Pac Surveill Response J
. 2024 Mar;
15(1):1-2.
PMID: 38500773
No abstract available.
4.
Kitamura N, Otani K, Kinoshita R, Yan F, Takizawa Y, Fukushima K, et al.
Lancet Reg Health West Pac
. 2024 Jan;
41:100911.
PMID: 38223396
Background: The Omicron variant of SARS-CoV-2 was reported to evade immunity derived from vaccination and previous infection. A better understanding of hybrid immunity informs effective infection control strategies. Since the...
5.
Kayano T, Ko Y, Otani K, Kobayashi T, Suzuki M, Nishiura H
Sci Rep
. 2023 Oct;
13(1):17762.
PMID: 37853098
Japan implemented its nationwide vaccination program against COVID-19 in 2021, immunizing more than one million people (approximately 1%) a day. However, the direct and indirect impacts of the program at...
6.
Ko Y, Furuse Y, Otani K, Yamauchi M, Ninomiya K, Saito M, et al.
Sci Rep
. 2023 Aug;
13(1):13230.
PMID: 37580339
Japan has implemented a cluster-based approach for coronavirus disease 2019 (COVID-19) from the pandemic's beginning based on the transmission heterogeneity (overdispersion) of severe acute respiratory coronavirus 2 (SARS-CoV-2). However, studies...
7.
Malaga J, Pajuelo M, Okamoto M, Kagning Tsinda E, Otani K, Tsukayama P, et al.
Viruses
. 2023 Jun;
15(6).
PMID: 37376555
Rapid molecular testing for severe acute respiratory coronavirus 2 (SARS-CoV-2) variants may contribute to the development of public health measures, particularly in resource-limited areas. Reverse transcription recombinase polymerase amplification using...
8.
Miyahara R, Tamura K, Kato T, Nakazaki M, Otani K, Ko Y, et al.
Emerg Infect Dis
. 2023 Jun;
29(8):1648-1650.
PMID: 37343546
To determine the effects of age and variants of concern on transmission of SARS-CoV-2, we analyzed infection rates among close contacts over 4 periods in Toyama Prefecture, Japan. Among household...
9.
Imamura T, Watanabe A, Serizawa Y, Nakashita M, Saito M, Okada M, et al.
JAMA Netw Open
. 2023 Feb;
6(2):e230589.
PMID: 36826818
Importance: There have been few studies on the heterogeneous interconnection of COVID-19 outbreaks occurring in different social settings using robust, surveillance epidemiological data. Objectives: To describe the characteristics of COVID-19...
10.
Arashiro T, Arai S, Kinoshita R, Otani K, Miyamoto S, Yoneoka D, et al.
Influenza Other Respir Viruses
. 2023 Feb;
17(2):e13094.
PMID: 36824391
Background: Based on routine surveillance data, Japan has been affected much less by COVID-19 compared with other countries. To validate this, we aimed to estimate SARS-CoV-2 seroprevalence and examine sociodemographic...